John Is A 35-Year-Old Nurse With Rheumatic Fever As A Child

John Is A 35 Year Old Nurse Who Had Rheumatic Fever As a Child

John is a 35-year-old nurse who experienced rheumatic fever during childhood. Currently, he presents with symptoms including persistent tachycardia and light-headedness. Diagnostic evaluations reveal an enlarged left atrium and ventricle on chest X-ray, and ECG indicates atrial fibrillation along with mild pulmonary congestion. Cardiac measurements show a cardiac output (CO) of 3.4 L/min, blood pressure (BP) of 100/58 mm Hg, left atrial pressure (LAP) of 16 mm Hg, and right ventricular pressure (RVP) of 44/8 mm Hg. Heart sounds suggest valvular regurgitation. Based on this clinical presentation, multiple questions are posed concerning the specific valvular pathology, its anatomical assessment, associated heart sounds, effects of different valvular incompetence, and underlying causes of his symptoms.

Paper For Above instruction

To address the first question regarding which atrioventricular (A-V) valve is incompetent, the clinical findings provide significant clues. The presence of valvular regurgitation, along with an enlarged left atrium and ventricle, suggests that the mitral valve (which is the A-V valve between the left atrium and left ventricle) is likely damaged and incompetent. Rheumatic fever often leads to rheumatic valvulitis, which predominantly affects the mitral valve, causing thickening, fusion of commissures, and ultimately regurgitation or stenosis. In John's case, the regurgitation appears to be mitral because of the characteristic enlarged left atrium, which results from backward flow of blood through a leaky mitral valve into the atrium during ventricular systole. Therefore, it can be deduced that the mitral valve is incompetent, allowing blood to flow backward into the left atrium during ventricular contraction.

Concerning the anatomical location for auscultation of this valvular disorder, the regurgitation from the mitral valve is best heard at the apex of the heart. The apex is located at the fifth intercostal space, midclavicular line, where the heart's apex touches the chest wall. Auscultation with a stethoscope over this area would reveal abnormal sounds associated with mitral regurgitation, such as a pansystolic (holosystolic) murmur that radiates toward the axilla. This region allows clinicians to listen directly to the mitral area and detect murmurs associated with valvular incompetence. Proper use of the diaphragm of the stethoscope in this location enhances the ability to identify the murmur's timing, pitch, and duration.

Regarding the heart sound that would be pronounced and lengthened, the murmur caused by mitral regurgitation is typically a loud, pansystolic (holosystolic) murmur. It begins with the onset of systole and continues throughout, often peaking in mid-systole and extending to the end of systole. Because of the backflow of blood into the atrium, the second heart sound (S2) may also be accentuated due to increased blood volume ejected back into the pulmonary circulation, but the primary abnormal sound is the regurgitant murmur. The lengthening and loudness of this murmur occur because the volume of regurgitant blood fluctuates during systole, causing a longer duration of turbulent flow and thus an audible and prolonged murmur.

If instead the other atrioventricular valve—the tricuspid valve—were incompetent rather than the mitral valve, the cardiopulmonary parameters could be affected differently. An incompetent tricuspid valve would lead to regurgitation of blood from the right ventricle into the right atrium during systole. This could increase right atrial pressure, potentially elevating right atrial and pulmonary pressures. Consequently, cardiac output might be reduced if right-sided failure occurs, leading to lowered systemic blood pressure, or it could cause congestion in the systemic venous system and peripheral edema. The right ventricular pressure (RVP) might increase due to volume overload, and pulmonary circulation could be affected indirectly. However, since John's measurements already show mild pulmonary congestion and a relatively low BP, improper functioning of the tricuspid valve might only modify these parameters subtly unless the regurgitation becomes severe. Typically, the main differences would involve right-sided pressures and the pattern of pulmonary congestion, with potential impacts on overall CO depending on the severity of the valvular incompetence.

Finally, the causes of John's tachycardia, light-headedness, and mild pulmonary congestion can be attributed to the hemodynamic effects of valvular incompetence and atrial fibrillation. The regurgitation results in volume overload of the left atrium and ventricle, leading to increased atrial pressures and atrial dilation. This dilation predisposes to atrial fibrillation, which is characterized by rapid and irregular atrial contractions, thus causing tachycardia. The persistent tachycardia reduces cardiac efficiency, contributing to light-headedness and decreased cerebral perfusion. Moreover, the valvular insufficiency and atrial fibrillation impair effective blood ejection during systole, reducing cardiac output as reflected in the low CO measurement (3.4 L/min). The increased left atrial pressure (16 mm Hg) and pulmonary congestion are manifestations of backward failure, where blood backs up into pulmonary circulation, causing mild pulmonary edema and congestion. These pathophysiologic disturbances are compounded by the effects of rheumatic damage to the valves, which persists even long after the initial infection, leading to chronic volume overload, atrial dilation, and subsequent arrhythmias.

References

• Braunwald, E., et al. (2019). Harrison's Principles of Internal Medicine (20th ed.). McGraw-Hill Education.
• Nishimura, R. A., & Tajik, A. J. (2014). Clinical diagnosis of valvular heart disease: A practical approach. Heart, 100(3), 192–200.
• Cheitlin, M. D., et al. (2018). Valvular heart disease. Circulation, 138(12), e33–e55.
• Carabello, B. A., & Paulus, W. J. (2015). Aortic stenosis. The New England Journal of Medicine, 372(10), 965–973.
• Zoghbi, W. A., et al. (2017). Recommendations for evaluation of native valvular regurgitation. Journal of the American Society of Echocardiography, 30(4), 303–371.
• Yucel, E., et al. (2014). Pathophysiology of rheumatic heart disease and valvular regurgitation. Turkish Journal of Cardiology, 29(4), 464–477.
• Shah, M., et al. (2020). Echocardiographic assessment of valvular disease. Current Cardiology Reports, 22(10), 99.
• Greenberg, M. S. (2012). Rheumatic fever and rheumatic heart disease. Pediatric Clinics of North America, 59(3), 613–631.
• Bonow, R. O., et al. (2019). ACC/AHA Guideline for the management of patients with valvular heart disease. Journal of the American College of Cardiology, 73(13), e57–e184.
• Wang, J., et al. (2016). Pathophysiology and management of atrial fibrillation in valvular heart disease. Cardiology Clinics, 34(2), 193–200.